Thomas Fratacci
Director of Finance/CFO at BIOTECH ACQUISITION COMPANY
Profile
Thomas Fratacci is currently the Chief Financial Officer at Sprim Ventures Pte Ltd., Biotech Acquisition Co., and Sprim Global Investments Pte Ltd.
He previously worked as the Chief Executive Officer at WPP Group USA, Inc., Director at Travecta Therapeutics Pte Ltd., and Group Chief Financial Officer at SPRIM.
Fratacci is a graduate of École des Hautes Études Commerciales du Nord.
Thomas Fratacci active positions
| Companies | Position | Start |
|---|---|---|
| BIOTECH ACQUISITION COMPANY | Director of Finance/CFO | 01/09/2020 |
Sprim Ventures Pte Ltd.
 Sprim Ventures Pte Ltd. Investment ManagersFinance Sprim Ventures Pte Ltd (Sprim Ventures) is a venture capital firm founded by Michael Shleifer, Ivan Jarry and Laurent Benissan in 2015. The firm is headquartered in Singapore. | Director of Finance/CFO | - |
| Sprim Global Investments Pte Ltd. | Director of Finance/CFO | - |
Former positions of Thomas Fratacci
| Companies | Position | End |
|---|---|---|
SPRIM
 SPRIM Medical/Nursing ServicesHealth Services SPRIM provides health prevention research and information consulting services. It offers research and clinical services, health marketing and communications, issue and quality management, and regulatory and scientific affairs services. The company was founded by Michael Shleifer, Ivan Jarry and Olivier Shleifer and is headquartered in Paris, France. | Director of Finance/CFO | - |
WPP Group USA, Inc.
 WPP Group USA, Inc. Advertising/Marketing ServicesCommercial Services WPP Group USA, Inc. provides communications and media management services. The company is headquartered in New York, NY. | Chief Executive Officer | - |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Director/Board Member | - |
Training of Thomas Fratacci
| École des Hautes Études Commerciales du Nord | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sprim Ventures Pte Ltd.
Sprim Ventures Pte Ltd. Investment ManagersFinance Sprim Ventures Pte Ltd (Sprim Ventures) is a venture capital firm founded by Michael Shleifer, Ivan Jarry and Laurent Benissan in 2015. The firm is headquartered in Singapore. | Finance |
Biotech Acquisition Co.
 Biotech Acquisition Co. Financial ConglomeratesFinance Biotech Acquisition Co. is a blank check company, which engages in the effectuation of a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one business. The company was founded on September 3, 2020 and is headquartered in New York, NY. | Finance |
| Sprim Global Investments Pte Ltd. | |
Travecta Therapeutics Pte Ltd.
Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Technology Services |
SPRIM
SPRIM Medical/Nursing ServicesHealth Services SPRIM provides health prevention research and information consulting services. It offers research and clinical services, health marketing and communications, issue and quality management, and regulatory and scientific affairs services. The company was founded by Michael Shleifer, Ivan Jarry and Olivier Shleifer and is headquartered in Paris, France. | Health Services |
WPP Group USA, Inc.
WPP Group USA, Inc. Advertising/Marketing ServicesCommercial Services WPP Group USA, Inc. provides communications and media management services. The company is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Thomas Fratacci
